CoChat

Of Mice and Men: The Tale of Steroidogenic Factor-1

Jameson, J. Larry · 2004 · The Journal of Clinical Endocrinology & Metabolism
Cited by 50

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

In John Steinbeck’s famous novel, George and Lennie dream of a simple bucolic life, living on a ranch in southern California (1). However, as foreshadowed by the poem on which the title is based, their best-laid plans go awry. In medicine, we harbor similarly simplistic views of the world, if for no other reason than to bring order to complex physiological events or to provide a framework for testing ideas. More often than not, these models are incomplete, if not altogether wrong. Nonetheless, this hypothesis-driven approach is the foundation of our scientific method. In this editorial, I will highlight the interplay between genetic models in mice and our understanding of inherited reproductive disorders in man, focusing on recent findings involving steroidogenic factor-1 (SF-1). Increasingly, mouse models help to unravel complex physiological pathways, including the regulation of reproduction (2). Genetic studies in humans historically have been based on testing candidate genes or performing linkage studies, which are rarely applicable when reproduction is compromised. Mice provide an opportunity for performing targeted mutagenesis, including knockout and knock-in approaches, as well as transgenic expression of genes (3). More recently, ethylnitrosourea and transgenic insertional mutagenesis enable “forward genetic” approaches that use phenotypic screens to identify novel genes (4). Although we often focus on the differences in mouse and human phenotypes caused by mutations in homologous genes, it is notable that different inbred strains of mice also differ considerably in the phenotypic expression of traits; this feature potentially allows the identification of modifier genes in mice of different genetic backgrounds (5). A few examples in the field of reproduction illustrate the conceptual advantages conferred by parallel studies in humans and in mice. This year, a report described hypogonadotropic hypogonadism caused by mutations in GPR54, a G protein-coupled seven-transmembrane receptor proposed to regulate puberty and gonadotropin production (6). Linkage studies and mutational analyses in humans were accompanied by characterization of a GPR54 knockout mouse, providing independent lines of evidence that this receptor plays a key role in reactivation of the GnRH pulse generator (6, 7). The DAX1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X chromosome, gene 1) gene was identified in humans with X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. A Dax1 knockout model in mice revealed a primary testicular defect that had been unrecognized in humans because of concomitant gonadotropin deficiency (8, 9). A series of recent reports on SF-1 mutations in humans reveal a surprisingly broad spectrum of phenotypic features (10–15) and underscore the dose-dependent action of SF-1. What were the critical steps that brought us to this level of understanding? SF-1 (also known as adrenal 4-binding protein, Ad4BP) was originally identified as a transcription factor that binds to DNA regulatory elements in the proximal promoter regions of steroidogenic enzyme genes (16). In fact, SF-1 is considered a master regulator of reproduction, because its targets include genes at every level of the hypothalamic-pituitary-gonadal axis, as well as most genes involved in gonadal and adrenal steroidogenesis. The cloning of bovine and mouse genes encoding Sf-1 revealed that it resembled the Drosophila orphan nuclear receptor, fushi tarazu factor-1 (Ftz), a gene involved in segmentation. The human SF-1 gene (officially designated NR5A1) encodes a 461-amino-acid protein that shares structural similarities with members of the nuclear receptor superfamily. Like other nuclear receptors, SF-1 binds to specific DNA sequences in target genes and regulates transcription. Specifically, it binds to DNA as a monomer and recognizes variations of the DNA sequence motif, T/CCA AGGTCA (17). In most cases, SF-1 functions cooperatively with other transcription factors to modulate the timing and level of gene expression. It is this cooperative interaction with other factors that allows it to regulate so many target genes, which differ widely in their expression patterns and regulation. Critical structural regions in SF-1 include a zinc finger DNA binding domain, an “A” box (or FTZF1 box) accessory DNA-binding domain, a hinge region, and an activation function-2 domain involved in transcriptional control. Unlike many classical nuclear receptors, such as the estrogen, glucocorticoid, or thyroid hormone receptors, there is no known ligand that regulates SF-1-mediated transcription. Consequently, it is classified as an orphan nuclear receptor to recognize the possibility that a ligand may yet be discovered. It is possible, however, that SF-1 is regulated independently of a specific ligand; its pattern and level of expression, interaction with other transcription factors, or posttranslational modific

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2004-2047

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 50

Metadata

Authors
Jameson, J. L.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2004-12-01
Volume
89
Issue
12
Pages
5927-5929
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W1975207593
Cited by
50
References
10
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.